TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details






Profile for Eric MacLaughlin, Pharm.D., FASHP, FCCP, BCPS

Eric MacLaughlin

Eric MacLaughlin, Pharm.D., FASHP, FCCP, BCPS

  • Professor
  • Interim Chair, Department of Pharmacy Practice
Office Phone: 806-414-9302
Email: Eric.MacLaughlin@ttuhsc.edu
Mail Address: 1300 S Coulter St
Amarillo TX 79106-1712

Biography

Eric MacLaughlin, Pharm.D., FCCP, BCPS is Professor and Interim Chair, Department of Pharmacy Practice at Texas Tech University Health Sciences Center School of Pharmacy. He is also a Professor in the Departments of Family Medicine and Internal Medicine at TTUHSC School of Medicine. He received his B.S. in Pharmacy from Albany College of Pharmacy, Pharm.D. from the Medical University of South Carolina, and completed a Primary Care Specialty Residency at the University of Colorado. His practice specialty is family medicine. Dr. MacLaughlin’s research interests include management of hypertension, prevention and of treatment of osteoporosis, and education of healthcare professionals.

Research Interests

Dr. MacLaughlin's scholarship and research interests include prevention and of treatment of osteoporosis, health professions education, and optimizing management of cardiovascular diseases (e.g., hypertension, hyperlipidemia, congestive heart failure).

Selected Publications:

  • Saseen JJ, MacLaughlin EJ. Chapter 3, Hypertension. In: Dipro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds.. Pharmacotherapy: A Pathophysiologic Approach. (9th):in press.
  • Fike DS, Zorek J, MacLaughlin EJ, MacLaughlin A, Samiuddin M, Young RB. Student perceptions of physician-pharmacist interprofessional clinical education (SPICE): instrument development and validation. Am J Pharm Educ. 2013;77(9):Article 190.
  • MacLaughlin EJ, Ardery G, Jackson EA, Ives TJ, Young RB, Fike DS, Carter BL. Institutional review board barriers and solutions encountered in the collaboration among pharmacists and physicians to improve outcomes now (CAPTION) study: a national, multicenter, practice-based implementation trial. Pharmacotherapy. 2013;33(9):902-911.
  • Fernandez CH, MacLaughlin EJ, Dore NL, Ebsary S. Assessing the potential adverse consequences of supplemental calcium on cardiovascular outcomes: should we change our approach to bone health?. Ann Pharmacother. 2012;46(5):696-702.
  • Fernandez CH, MacLaughlin EJ, Dore NL. Comment: assessing the potential adverse consequences of supplemental calcium on cardiovascular outcomes: should we change our approach to bone health?-Reply-I. Ann Pharmacother. 2012;46(9):1268-1270.
©